PMID: 9555760Apr 29, 1998Paper

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

JAMA : the Journal of the American Medical Association
J LazarouP N Corey

Abstract

To estimate the incidence of serious and fatal adverse drug reactions (ADR) in hospital patients. Four electronic databases were searched from 1966 to 1996. Of 153, we selected 39 prospective studies from US hospitals. Data extracted independently by 2 investigators were analyzed by a random-effects model. To obtain the overall incidence of ADRs in hospitalized patients, we combined the incidence of ADRs occurring while in the hospital plus the incidence of ADRs causing admission to hospital. We excluded errors in drug administration, noncompliance, overdose, drug abuse, therapeutic failures, and possible ADRs. Serious ADRs were defined as those that required hospitalization, were permanently disabling, or resulted in death. The overall incidence of serious ADRs was 6.7% (95% confidence interval [CI], 5.2%-8.2%) and of fatal ADRs was 0.32% (95% CI, 0.23%-0.41%) of hospitalized patients. We estimated that in 1994 overall 2216000 (1721000-2711000) hospitalized patients had serious ADRs and 106000 (76000-137000) had fatal ADRs, making these reactions between the fourth and sixth leading cause of death. The incidence of serious and fatal ADRs in US hospitals was found to be extremely high. While our results must be viewed with circ...Continue Reading

Associated Clinical Trials

Citations

Jun 27, 2014·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Ehsan NabovatiSaeid Eslami
Jan 24, 2014·Molecular Diagnosis & Therapy·David Durham
Aug 13, 2010·Biomarkers in Medicine·Yuqiu Jiang, Mu Wang
Dec 3, 2010·Pharmacogenomics·Mara L Becker, J Steven Leeder
Mar 24, 2015·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·V VijayabhaskarSriram Rajagopal
Dec 19, 2013·BioMed Research International·C CantisaniS Calvieri
Nov 3, 2010·Journal of Young Pharmacists : JYP·G Jeetu, G Anusha
Jan 18, 2013·Journal of Pharmacology & Pharmacotherapeutics·Maulik S DoshiRam K Dikshit
Dec 23, 2006·Pharmacogenomics·Thierry Dervieux, Mohan V Bala
Jun 4, 2008·Future Oncology·Christos ApostolopoulosGeorgios Giamas
Oct 28, 2010·Nihon rinsho. Japanese journal of clinical medicine·Yoshiro SaitoJun-ichi Sawada
Dec 19, 2007·Pharmacogenomics·Joseph R BertinoPrasun J Mishra
Apr 30, 2010·Personalized Medicine·Prasun J Mishra
Jan 19, 2013·Pharmacogenomics·Daniela J ConradoMichael A Pacanowski
Aug 7, 2008·Pharmacogenomics·David S Wishart
Oct 12, 2013·Annual Review of Medicine·Peter Weeke, Dan M Roden
Feb 20, 2002·British Journal of Clinical Pharmacology·Annie Pierre Jonville-BéraElisabeth Autret-Leca
Aug 8, 2008·Future Oncology·Ruty Mehrian ShaiThomas C Chen
Jul 17, 2009·Pharmacogenomics·Paul J Jannetto, Nancy C Bratanow
Mar 20, 2010·Pharmacogenomics·Laurent Becquemont
Dec 24, 2013·European Journal of Clinical Pharmacology·Consuelo PedrósJosep Maria Arnau
Apr 4, 2008·Pharmacogenomics·Howard Coleman, Kristine Ashcraft
May 19, 2010·Biomarkers in Medicine·Paul de Koning, James Keirns
Mar 8, 2014·Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen·Uvo M HölscherPetra A Thürmann
Jul 27, 2006·Southern Medical Journal·Steven Joseph Haas
Feb 5, 2008·Pharmacogenomics·David S Wishart
Nov 7, 2012·Journal of Pharmacology & Pharmacotherapeutics·Anshi Singh, Parloop Bhatt
Sep 11, 2008·Pharmacogenomics·Chris Cotsapas
Nov 1, 2010·Therapeutic Delivery·Leslie Garson, Bill Bruns
Mar 31, 2010·Pharmacogenomics·Yuxia Cui, Richard S Paules
Oct 19, 2012·Indian Journal of Dermatology, Venereology and Leprology·Siew-Eng Choon, Nai-Ming Lai
Apr 17, 2013·The Pharmacogenomics Journal·F AminkengUNKNOWN Canadian Pharmacogenomics Network for Drug Safety Consortium

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.